Efficacy of mirabegron for overactive bladder with human T cell lymphotropic virus-1 associated myelopathy.
Tomohiro MatsuoYasuyoshi MiyataTatsufumi NakamuraKatsuya SatohHideki SakaiPublished in: Lower urinary tract symptoms (2018)
Mirabegron administration improved subjective symptoms in HAM/TSP patients with neurogenic OAB.